ACT34-CMI

CD34+ cellular therapy · Lisata Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACT34-CMI, covering 2021-01-08 to 2021-01-08. Get the full timeline:

Most recent: Clinical Trial Update: ACT34-CMI -- Adult Autologous CD34+ Cells [Phase 2]